Safer stem cell transplants? new study aims to reduce Life-Threatening side effects
NCT ID NCT01174108
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 30 times
Summary
This study tests a new way to do stem cell transplants for people with severe aplastic anemia and other bone marrow failure diseases. The goal is to lower the risk of serious complications, like graft-versus-host disease, by giving fewer donor white blood cells. Participants receive chemotherapy to prepare their body, then a transplant of donor stem cells and a small number of white blood cells. They must take anti-rejection drugs for several months after the transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE APLASTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland, Baltimore (UMB)
COMPLETEDBaltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.